Market Access News | pharmaphorum

News

Eli Lilly's Omvoh has been recommended for use in Crohn's disease by NICE, while BeOne's Brukinsa gets the go-ahead for mantle cell lymphoma.

News

Eli Lilly has won FDA approval for a new regimen for its Alzheimer's disease therapy Kisunla, which carries a reduced risk of side effects.

News

Novo Nordisk has moved quickly to file for approval of a higher-dose version of obesity drug Wegovy as it fends off stiff competition from Eli Lilly.

News

A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young children.

News

Medical groups have sued HHS Secretary Robert F Kennedy Jr for removing healthy children and pregnant women from COVID-19 shot recommendations.

News

KalVista has brought the first oral, on-demand treatment for hereditary angioedema attacks to the US market.